Software system to predict the infection in COVID-19 patients using deep learning and web of things.

Since the end of 2019, computed tomography (CT) images have been used as an important substitute for the time-consuming Reverse Transcriptase polymerase chain reaction (RT-PCR) test; a new coronavirus 2019 (COVID-19) disease has been detected and has quickly spread through many countries across the world. Medical imaging such as computed tomography provides great potential due to growing skepticism toward the sensitivity of RT-PCR as a screening tool. For this purpose, automated image segmentation is highly desired for a clinical decision aid and disease monitoring. However, there is limited publicly accessible COVID-19 image knowledge, leading to the overfitting of conventional approaches. To address this issue, the present paper focuses on data augmentation techniques to create synthetic data. Further, a framework has been proposed using WoT and traditional U-Net with EfficientNet B0 to segment the COVID Radiopedia and Medseg datasets automatically. The framework achieves an F-score of 0.96, which is best among state-of-the-art methods. The performance of the proposed framework also computed using Sensitivity, Specificity, and Dice-coefficient, achieves 84.5%, 93.9%, and 65.0%, respectively. Finally, the proposed work is validated using three quality of service (QoS) parameters such as server latency, response time, and network latency which improves the performance by 8%, 7%, and 10%, respectively.

eBreCaP: extreme learning-based model for breast cancer survival prediction.

Breast cancer is the second leading cause of death in the world. Breast cancer research is focused towards its early prediction, diagnosis, and prognosis. Breast cancer can be predicted on omics profiles, clinical tests, and pathological images. The omics profiles comprise of genomic, proteomic, and transcriptomic profiles that are available as high-dimensional datasets. Survival prediction is carried out on omics data to predict early the onset of disease, relapse, reoccurrence of diseases, and biomarker identification. The early prediction of breast cancer is desired for the effective treatment of patients as delay can aggravate the staging of cancer. In this study, extreme learning machine (ELM) based model for breast cancer survival prediction named eBreCaP is proposed. It integrates the genomic (gene expression, copy number alteration, DNA methylation, protein expression) and pathological image datasets; and trains them using an ensemble of ELM with the six best-chosen models suitable to be applied on integrated data. eBreCaP has been evaluated on nine performance parameters, namely sensitivity, specificity, precision, accuracy, Matthews correlation coefficient, area under curve, area under precision-recall, hazard ratio, and concordance Index. eBreCaP has achieved an accuracy of 85% for early breast cancer survival prediction using the ensemble of ELM with gradient boosting.